Alternative medical and surgical options to hysterectomy

被引:37
作者
Banu, NS [1 ]
Manyonda, IT [1 ]
机构
[1] St Georges Healthcare NHS Trust, Dept Obstet & Gynaecol, London SW17 0QT, England
关键词
hysterectomy; LNG-IUS; endometrial ablation; myomectomy; uterine artery embolization;
D O I
10.1016/j.bpobgyn.2005.01.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The range of alternatives to hysterectomy includes 'expanded' oral medical regimens, the levonorgestrel-releasing intrauterine system (LNG-IUS), a wide range of endometrial ablative techniques, and-where fibroids are the primary pathology-myomectomy and uterine artery embolization. Since research has shown that hysterectomy is a highly effective treatment, these alternatives must be assessed against the recognized high satisfaction rates and improved quality of life reported following hysterectomy. Additional issues that would also need to be addressed include complication rates, side-effects, and cost-effectiveness. For women with prolonged abnormal uterine bleeding, recent research suggests that hysterectomy is significantly superior to an expanded medical treatment regimen for health-related quality-of-life measures. Satisfaction with treatment, and health-related quality of life and psychosocial well-being, are reportedly similar between hysterectomy and the LNG-IUS, but the latter has the advantage of reduced cost. Endometrial ablation reduces menstrual blood flow, but its benefits relative to hysterectomy lessen over time. No large-scale studies have adequately compared uterine artery embolization or myomectomy to hysterectomy. Perhaps the most telling finding from recent research with respect to the place of alternative therapies to hysterectomy is that the existence or advent of these alternatives has not reduced hysterectomy rates, but merely increased treatment options and interventions for excessive menstrual loss.
引用
收藏
页码:431 / 449
页数:19
相关论文
共 118 条
[71]  
Minaguchi H, 2000, J REPROD MED, V45, P481
[72]  
Miskry T, 1999, Semin Laparosc Surg, V6, P73
[73]   Management of uterine leiomyomata: What do we really know? [J].
Myers, ER ;
Barber, MD ;
Gustilo-Ashby, T ;
Couchman, G ;
Matchar, DB ;
McCrory, DC .
OBSTETRICS AND GYNECOLOGY, 2002, 100 (01) :8-17
[74]   INCIDENCE OF SYMPTOM RECURRENCE AFTER HYSTERECTOMY FOR ENDOMETRIOSIS [J].
NAMNOUM, AB ;
GEHLBACH, DL ;
HICKMAN, TN ;
ROCK, JA ;
GOODMAN, SB .
FERTILITY AND STERILITY, 1995, 64 (05) :898-902
[75]  
National Advisory Committee on Health and Disability, 1998, GUID MAN HEAV MENSTR
[76]  
Nevadunsky NS, 2001, J REPROD MED, V46, P870
[77]  
NEZHAT C, 1991, INT J FERTIL, V36, P275
[78]   Recurrence rate after laparoscopic myomectomy [J].
Nezhat, FR ;
Roemisch, M ;
Nezhat, CH ;
Seidman, DS ;
Nezhat, CR .
JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS, 1998, 5 (03) :237-240
[79]   Endometrial resection for the treatment of menorrhagia [J].
OConnor, H ;
Magos, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (03) :151-156
[80]   COMPARATIVE-STUDY OF TRANEXAMIC ACID AND NORETHISTERONE IN THE TREATMENT OF OVULATORY MENORRHAGIA [J].
PRESTON, JT ;
CAMERON, IT ;
ADAMS, EJ ;
SMITH, SK .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1995, 102 (05) :401-406